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ABSTRACT 
 
The family of WNT lipoglycoproteins consists of 19 secreted proteins that are 
important for multiple cellular processes including cell proliferation, migration and fate. 
WNTs induce signalling cascades by binding the seven transmembrane receptors named 
Frizzleds (FZDs) classified as G protein-coupled receptors (GPCRs). Binding of WNT 
proteins to FZDs leads to the activation of either β-catenin-dependent and/or β-catenin–
independent pathways. Mutations or misregulation in the WNT signalling components can 
cause severe developmental defects, and disorders such as cancer.  
During embryonic development WNT/FZD signalling is one of the key regulators of 
vascular development in the central nervous system (CNS). Ablation of the transcriptional 
activator β-catenin resulted in haemorrhage throughout the entire CNS. Moreover, deletion 
of one of the WNT receptors, FZD4, also exhibited vascular defects, which were mainly 
localised to the retina.  
In this thesis we investigated the process leading to CNS haemorrhage by creating a 
novel mouse model where β-catenin was inhibited. By overexpressing AXIN1, one of the 
major components of the β-catenin destruction complex, we could conclude that inhibition 
of β-catenin in CNS endothelium increased vessel regression and remodelling. 
Furthermore, we identified an extracellular matrix protein, ADAMTS-Like Protein 2 
(ADAMTSL2), to be important for proper vascularisation of the brain. In addition, RNA 
sequencing data of the embryonic forebrain endothelial cells provided us with the FZD 
expression profile revealing that FZD4 and its close homolog FZD10 are present during 
early blood vessels development.  
Even though FZDs are classified as GPCRs, the question as to whether they can 
activate G proteins has been under the debate. Despite sequence homology indicating a 
structure similar to other classical GPCRs, the evidence that they can signal through G 
proteins has been limited due to a lack of pharmacological tools and robust read-out 
assays.  
Here, we show for the first time that the two WNT receptors, FZD4 and FZD10 
belonging to the same FZD homology cluster, form inactive-state complexes with the 
Gα12/13 proteins. Moreover, we show that FZD4, the receptor previously connected to 
vascular malformations is able to induce Gα12/13-dependent recruitment of p115-
RHOGEF, suggesting a novel FZD4/Gα12/13/RHO signalling axis. In addition, we 
demonstrate that FZD10 has a selective preference for Gα13 over other G protein family 
members. While FZD10 is able to activate β-catenin transcriptional activity in the presence 
of overexpressed LRP6, FZD10 triggers Gα12/13-dependent transcriptional activity of Yes 
Associated Protein 1 (YAP) and Tafazzin (TAZ) in the absence of its co-receptor. 
Furthermore, we confirm by in situ hybridisation that as indicated in the RNA sequencing 
data, FZD10 mRNA is indeed present in the developing CNS endothelium.  
Much like WNT/β-catenin signalling also Gα12/13 dependent signalling is crucial for 
proper vascular development. With that in mind and with the data presented in this thesis, 
I would like to propose a parallel route for WNT/FZD induced signalling during CNS 
vascular development, mediated through the Gα12/13 proteins.    
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1 INTRODUCTION 
 
1.1 WNT SIGNALLING PATHWAY 
 
1.1.1 WNT proteins 
 
Almost a century ago, the first members of the Wingless/Int-1 (WNT) family were 
described in mammals, (Bittner, 1936; Korteweg, 1936) but it took another fifty years 
before Roel Nusse and Harold Varmus gave the full description of the gene (Nusse and 
Varmus, 1982). Today, we know that the family of WNT proteins, consists of 19 secreted 
membera able to signal both short- and long-range, serving as extracellular growth factors 
(Fung et al., 1985; Logan and Nusse, 2004; MacDonald et al., 2009a; van Ooyen and 
Nusse, 1984). The structure of WNTs enables them to act as mediators in cell to cell 
communication, with an N-terminal signal sequence, followed by conserved cysteines 
with palmitoylation sites, making them hydrophobic (Logan and Nusse, 2004; Nusse, 
2005; Willert et al., 2003). Processes such as tissue patterning and homeostasis, cell 
migration and proliferation are all dependent on proper signalling by the WNT proteins 
(Nusse et al., 2008). Secreted WNTs are usually spread throughout the tissue by means of 
a concentration gradient, where WNT responsive cells at the same time sense the signal 
and respond to it, in a concentration-dependent manner (Neumann and Cohen, 1997; 
Zecca et al., 1996). 
From synthesis to secretion and signal induction, WNT proteins undergo several 
modifications important for their activity (Port and Basler, 2010). In the endoplasmic 
reticulum (ER), the multi-pass transmembrane protein Porcupine lipid modifies WNTs 
(Galli et al., 2007; van den Heuvel et al., 1993; Zhai et al., 2004). With the lipid 
modification in place, the WNT protein is sent to the Golgi apparatus, where it binds to the 
seven transmembrane protein Wntless (Wls). Together with Wls, WNT is transported to 
the plasma membrane, before it is secreted from the cell through exocytosis (Bänziger et 
al., 2006; Bartscherer et al., 2006; Goodman et al., 2006). Another post-translational 
modification that the WNT proteins possess is glycosylation. Glycosylation has been 
shown to play a crucial role both for secretion and activity of the protein (Komekado et al., 
2007; Kurayoshi et al., 2007; Smolich et al., 1993). 
While it is getting clearer how the WNT proteins are transported out from the cell the 
experimental data showing how they are transported between the cells is still poor. Lately, 
several hypotheses have been raised. One of these hypotheses suggests that the transfer of 
the WNT proteins is mediated by lipoproteins derived from body fat (Neumann et al., 
2009), while another suggests extracellular transport by exosomes (Gross et al., 2012; 
Korkut et al., 2009).  
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1.1.2 Frizzleds 
 
From neural tube closure, central nervous system (CNS) angiogenesis and blood-brain 
barrier (BBB) formation, to orientation of cellular structures and bone formation, the 
diverse roles of the main WNT receptors, Frizzleds (FZDs), clearly show their importance 
for proper developmental and homeostatic processes. FZDs are highly conserved among 
multicellular organisms and it is believed that they developed in order to allow complex 
tissue architecture. All FZDs, of which there are 10 in mammals, share a common 
structure. At the extracellular side, the receptors possess a ca. 36 amino acid long N-
terminal signal sequence. Directly after the signal sequence, follows the highly conserved 
extracellular cysteine-rich domain (CRD) that is connected to the seven transmembrane 
segments by a linker region (Fig.1). By sequence comparison, FZDs were separated into 
homology clusters wherein redundancy was observed with respect to function (Fig.2) 
(Bhanot et al., 1996; Hsieh et al., 1999; Janda et al., 2012; Schenkelaars et al., 2015; 
Schulte, 2010; Wang et al., 2016; Xu and Nusse, 1998).  
 
 
 
 
Figure 1: Illustration of the basic structure of the seven-transmembrane FZD receptor. At the extracellular 
N-terminus following the signal sequence is the cysteine rich domain that is in turn connected to the seven 
transmembrane helices by a linker region. On the intracellular side the DVL binding motif KTxxxW and 
intracellular loop (IL3) are visualized.  
 
After the first sequence description, indicating the presence of seven transmembrane 
helices as well as an extracellular N-terminus and an intracellular C-terminus, it was 
suggested that this group of receptors were G protein-coupled receptors (GPCR). 
Recently, this receptor family was grouped into a separate class of GPCRs together with 
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Smoothened (SMO) and is now included in the International Union of Basic and Clinical 
Pharmacology (IUPHAR) GPCR list under Class F or Class Frizzled (Foord et al., 2005; 
Schulte, 2010; Vinson et al., 1989).  
Even though FZDs are lacking some classical GPCR motifs, (Rosenbaum et al., 2009a; 
Wess, 1998) they share other characteristics of GPCRs like the charged residues at the C- 
and N-terminal ends of intracellular loop 3, known for their importance in receptor-G 
protein coupling. Another proposed factor important for the G protein coupling is the helix 
8 at the C-terminus. Structural analysis predicts the presence of such a stretch at the 
intracellular end of FZDs (Foord et al., 2005; Palczewski et al., 2000; Rasmussen et al., 
2007; Rosenbaum et al., 2009a; Schulte, 2010; Wess et al., 2008). In addition, the WNT 
receptors share several residues and the conserved KTxxxW domain for interaction with 
the phosphoprotein Dishevelled (DVL), which is another important component for 
WNT/FZD signalling (Gammons et al., 2016; Gao and Chen, 2010; Romero et al., 2010; 
Umbhauer et al., 2000; Wallingford and Habas, 2005; Wong et al., 2003).  
 
 
 
 
 
Figure 2: Schematic illustration presenting subfamilies of the class FZD GPCRs. Modified from Schulte 
2010.  
 
1.1.3 FZD4 
 
FZD4 is the receptor that is probably best understood. In both humans and mice, the 
phenotypes that are caused by non-functional FZD4 are often connected to vascular 
defects. Ablation of the receptor in mice results in severe defects in retinal vasculature, but 
also progressive hearing loss and cerebral degeneration associated with the loss of the 
BBB (Wang et al., 2001, 2012; Xu et al., 2004; Ye et al., 2009). In humans, mutation in 
FZD4 cause the syndrome known as familial exudative vitreoretinopathy (FEVR), where 
the retina is affected by hypo-vascularization (Nikopoulos et al., 2010; Qin et al., 2005; 
Robitaille et al., 2002; Toomes et al., 2004).  
In addition to acting as a WNT receptor, FZD4 is also a target receptor for the ligand 
Norrin. Norrin binds the FZD4 CRD domain and activates the downstream transcriptional 
activator ß-catenin. Disruption in Norrin signalling is known to cause the Norrie disease in 
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humans. A disorder characterized by progressive hearing loss and blindness. Using Norrin 
knock-out (KO) mice as a model system for Norrie disease showed that the retinal 
phenotype observed in these animals could be rescued by stabilization of ß-catenin in the 
developing endothelium (Luhmann et al., 2005; Rehm et al., 2002; Xu et al., 2004; Zhou 
et al., 2014a). 
 
1.1.4 FZD10 
 
While FZD4 is the best studied receptor, FZD10 remains the most enigmatic despite the 
close homology between these two receptors. Although FZD10 is expressed widely in the 
CNS, no evidence has so far been reported for a FZD10 loss-of-function phenotype (Kim et 
al., 2001; Zhao et al., 2006). The sparse data existing for FZD10 suggest that this receptor 
is involved both in embryonic development and in cancer. In the developing embryo, the 
mRNA expression levels of FZD10 are enhanced in the CNS (Y et al., 2009). At the same 
time, it has been shown that the expression pattern of FZD10 mRNA in the neural tube, 
limb buds and Müllerian duct, overlap with the expression of WNT-7A (Nunnally and 
Parr, 2004), a FZD ligand crucial for proper development of the BBB (Stenman et al., 
2008). In colorectal cancer, FZD10 has been implicated in the formation of tumours mainly 
through ß-catenin-dependent signalling (Terasaki et al., 2002). Upregulation of FZD10 in 
synovial sarcoma, contrary to colorectal cancer, results in ß-catenin-independent DVL-
RAC-JNK signalling. Here, it plays a role in both the development and progression of 
synovial sarcomas (Fukukawa et al., 2009). FZD10 is also one FZD family member that 
has been suggested to activate heterotrimeric G proteins (Koval and Katanaev, 2011). 
 
1.1.5 Co-receptors and other components of the WNT pathway 
 
Low-Density Lipoprotein (LDLR)-Related Proteins (LRPs) are a family of single-pass 
transmembrane proteins of which LRP5 and LRP6 are of importance for ß-catenin-
dependent signalling. By forming a complex together with FZD and WNT, LRPs act as 
co-receptors in the regulation of WNT responsive genes (Tamai et al., 2000; Wehrli et al., 
2000). Another co-receptor in the WNT signalling pathway is Receptor-Like Tyrosine 
Kinase (RYK). Similar to FZDs, RYK can bind to DVL and activate ß-catenin-dependent 
signalling. Receptor Tyrosine Kinese-Like Orphan Receptor 1 and 2 (ROR1 and ROR2) 
are also a type of tyrosine kinase receptor involved in WNT/FZD signalling pathway. 
ROR2 inhibits ß-catenin-dependent signalling through the binding of WNT-5A to its CRD 
motif (Mikels and Nusse, 2006).  
Among the multiple co-receptors, there are also other regulators of WNT signalling. 
Soluble Frizzled Related Proteins (SFRPs) and Dickkopf (DKK) belong to the group of 
proteins able to inhibit the WNT signalling pathway. While the SFRPs sequester WNTs 
extracellularly, they have also been shown to promote signalling by stabilizing WNT 
proteins and facilitating their secretion and transport (Hoang et al., 1996; Logan and 
Nusse, 2004). The action of DKK is somewhat different to SFRPs. Here, the inhibition of 
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signalling is achieved by promoting internalization and inactivation of LRP5/6 (Glinka et 
al., 1998; Mao et al., 2002).  
 
1.1.6 β-catenin-dependent signalling 
 
Interestingly, β-catenin-dependent signalling is the most studied WNT signalling 
pathway and has historically been referred to as the "canonical" pathway. In the absence of 
FZD ligands, β-catenin is part of a complex named the destruction complex, consisting of 
Axis Inhibition Protein (AXIN), Adenomatous Polyposis Coli Protein (APC), Glycogen 
Synthase Kinase 3 beta (GSK-3β) and Casein Kinase 1 (CK1). In the destruction complex, 
the amino terminal region of β-catenin is sequentially phosphorylated by CK1 and GSK-
3β. The phosphorylation gives rise to β-catenin ubiquitination by an E3 ubiqutin ligase 
subunit and subsequent degradation in the proteasome (Aberle et al., 1997; Amit et al., 
2002; Yost et al., 1996).  
 
 
Figure 3: Schematic illustration presenting β-catenin-dependent signalling pathway. In the absence (a) of 
FZD ligand, β-catenin is constantly targeted for proteasomal degradation. Binding of WNT to FZD and LRP 
(b) allows β-catenin to translocate to the nucleus and initiate transcriptional activities.  
 
In the presence of FZD ligands, a complex is formed between the receptor/ligand and 
the co-receptor LRP together with the scaffold protein DVL. This enables the 
phosphorylation of the co-receptor and the establishment of a docking site for AXIN to be 
recruited. Formation of this complex prevents degradation of β-catenin and promotes its 
nuclear accumulation, where β-catenin binds to the transcriptional factors T-Cell Factor 
(TCF) and Lymphoid-Enhancing Factor (LEF) homologs known as TCF/LEF.  TCF acts 
as a repressor in the absence of WNT by forming a complex with Groucho/Grg/TLE 
proteins. β-catenin presence in the nucleus physically displaces Groucho from the 
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TCF/LEF sites in order to activate WNT target genes (Cavallo et al., 1998; Daniels and 
Weis, 2005; Roose et al., 1998). Among these genes are cyclin D1 and c-myc (Fig.3) (He 
et al., 1998; Tetsu and McCormick, 1999).  
Besides acting as a transcriptional regulator, β-catenin also plays a major role in 
adherence junctions. Here, β-catenin serves as a binding partner to different cadherins 
(Peifer et al., 1992). 
 
1.1.7 β-catenin-independent signalling 
 
While WNT proteins and their receptors are capable of activating β-catenin-dependent 
signalling, there are also several signalling cascades that can be initiated independently of 
β-catenin. We refer to these cascades as β-catenin-independent signalling (Niehrs, 2012). 
In comparison to the β-catenin-dependent pathway, the knowledge about the independent 
pathways is still restricted, mostly because of poor characterization on the molecular level 
and a lack of robust readouts (Amerongen, 2012).  
So far, the best characterized pathway known to signal independently of β-catenin is the 
planar cell polarity pathway (PCP). PCP pathway is mainly important for guiding cells and 
structures. It is important for processes like cytoskeleton rearrangements, cell polarity and 
gene expression through activation of small monomeric G proteins or GTPases such as 
Ras-Related C3 Botulinum Toxin Substrate 1 (RAC1) and Ras Homolog Family Member 
A (RHOA) (Axelrod, 2009; Brown et al., 2006; Devenport and Fuchs, 2008; Heasman and 
Ridley, 2008; Kikuchi et al., 2011; Maung and Jenny, 2011; Schulte, 2010; Simons and 
Mlodzik, 2008). While activation of RAC1 is known to result in the initiation of c-Jun-N-
Terminal Kinase (JNK) and its stimulation of transcription factors like c-Jun and c-Fos, 
RHOA induction leads to the activation of the Rho Associated Kinase (ROCK) (Marlow 
et al., 2002; Rosso et al., 2005). Both RHOA and RAC1 have been reported to be induced 
by WNT proteins. For instance, cell migration induced by WNT-3A was shown to be 
mediated through DVL, RHOA and ROCK, while increased invasion and tumour 
aggressiveness was shown to be triggered by WNT/RAC signalling. In Xenopus gastrulae, 
it was demonstrated that WNT/FZD signalling regulates gastrulation through activation of 
either RHO or RAC. Modulating the function of these two GTPases perturbed the 
WNT/FZD dependent gastrulation. Moreover, inhibition of WNT-11/FZD signalling that 
is important for Xenopus gastrulation supressed RHO and RAC signalling (Endo et al., 
2005; Habas et al., 2003; Kishida et al., 2004; Kobune et al., 2007; Kurayoshi et al., 2006). 
An additional β-catenin-independent pathway regulates the intracellular calcium (Ca2+) 
levels. Overexpression of FZD2 in Danio rerio leads to elevation of intracellular Ca
2+
 in a 
G protein-dependent manner (Slusarski et al., 1997a). Increase of intracellular Ca
2+
 leads 
to activation of Ca
2+
/Calmodulin Dependent Kinases (CaMK), Protein Kinases (PKE) and 
Nuclear Factor of Activated T-Cells (NFAT). In mammalian cells, WNT-5A was shown 
to induce Ca
2+ 
signalling in order to regulate processes such as cell migration (Dejmek et 
al., 2006; Ishitani et al., 2003; Kühl et al., 2000; O’Connell et al., 2009; Sheldahl et al., 
2003; Weeraratna et al., 2002). 
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1.2 G PROTEIN-COUPLED RECEPTORS 
 
1.2.1 Heterotrimeric G proteins and G protein-coupled receptors 
 
G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors. 
By responding to diverse stimuli like ions, hormones and neurotransmitters, they are able 
to transduce extracellular signals into intracellular responses. Some of the functions 
regulated by GPCRs include the sensation of smell, taste and vision (Fredriksson et al., 
2003; Mahoney and Sunahara, 2016; Pierce et al., 2002). Interestingly, ca 30% of the 
currently marketed pharmaceutical drugs target GPCRs (Overington et al., 2006).  
GPCRs are characterized by the presence of seven transmembrane alpha helices and 
can be divided into five classes. The division is based on sequence and structural similarity 
and the receptor classification is referred to as Class A, Class B, Class C, Class Frizzled 
and Adhesion Class GPCRs or other 7 transmembrane (TM) receptors where class A is the 
largest family (Alexander et al., 2013; Fredriksson et al., 2003). Even though the members 
within a family share similarities, individual GPCRs have their own specific signal 
transduction activities and complex regulatory processes (Rosenbaum et al., 2009a).  
In the classical view, binding of an agonist to GPCRs leads to the activation of 
heterotrimeric G proteins, consisting of the Gβγ dimer and a Gα subunit which is 
classified into four classes: Gαs, Gαi/o, Gαq/11 and Gα12/13 (Casey and Gilman, 1988; Casey 
et al., 1988). By direct association between GPCRs and G proteins upon ligand 
stimulation, nucleotide exchange on the Gα subunit is promoted. Bound Guanosine 
Diphosphate (GDP) is displaced and the binding site is instead occupied by Guanosine 
Triphosphate (GTP) (McKee et al., 1999). Interaction between GPCRs and Gα has been 
proposed to occur through different modes. Interaction can either be achieved by an 
inactive state assembly between the receptor and the G protein or through collision 
coupling (Hein et al., 2005; Neubig, 1994; Oldham and Hamm, 2008; Qin et al., 2011). 
The occupancy of the free GDP site by GTP is driven by the high concentration of 
intracellular GTP. GTP binding induces a conformational change of the G protein 
subunits, where Gα dissociates from Gβγ, allowing them to regulate activity of specific 
effector proteins. For example, while Gα interacts with proteins such as adenylyl cyclase 
or phospholipase C, Gβγ can in parallel recruit proteins such as G protein-coupled receptor 
kinases (GRKs) to the plasma membrane (Mahoney and Sunahara, 2016). GPCRs are in 
general quite dynamic. The GDP dissociation from the Gα subunit is assumed to occur 
through allosteric disruption of the nucleotide binding site. According to the crystal 
structures of several Gα subunits, the nucleotide is buried between the two main domains 
of Gα, the Ras-Homolog Domain and the Alpha-Helical Domain. It is believed that 
rearrangements induced by a receptor, are needed in order for GDP to exit its site. These 
rearrangements include the embedding of the C-terminus of Gα into the core of the 
activated GPCR and interaction of the receptor with the Gα N-terminus (Chung et al., 
2011; Coleman et al., 1994; Herrmann et al., 2006; Noel et al., 1993; Rasmussen et al., 
2011; Sunahara et al., 1997; Tesmer et al., 2005). GPCRs respond dynamically to 
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orthosteric and allosteric input by a range of conformational changes. Allosteric effects 
can have an influence on the interaction of the receptor with various agonists. Specific 
GPCR ligands are believed to stabilize specific conformations that in turn affect the 
selection of the receptor effectors (Kenakin, 2013; Kobilka and Deupi, 2007).  
Intracellular changes of the receptor induced by the ligand are specific to the 
physiological system and its needs. Moreover, different ligands can have different 
efficacies for given GPCR, implying that the ligand interactions with the receptor are 
dependent on multiple interaction modes and not only occupation of the receptor binding 
site, in order to efficiently transfer energy between the binding pocket of the receptor and 
the G protein interaction site (Rosenbaum et al., 2009b). The diverse conformational 
changes of GPCRs can be observed if we take the example of the photoreceptor 
Rhodopsin and a GPCR with a diffusible agonist.  Light activation of Rhodopsin by 
photons triggers a conformational change of the receptor leading to a full 6Å outward 
movement of the intracellular end of transmembrane TM6 away from TM7. For GPCRs 
activated by a more diffusible agonist stimulation of the receptor does not necessary lead 
to a full outward movement of TM6 (Altenbach et al., 2008; Choe et al., 2011; Chung et 
al., 2011; Farrens et al., 1996; Gether et al., 1997; Ghanouni et al., 2001; Liu et al., 2012). 
 
1.2.2 Gα12/13 signalling 
 
Although discovered as recently as 1991, the understanding of the fourth class of  Gα 
proteins named Gα12/13 has progressed slower than with other G protein families 
(Strathmann and Simon, 1990). As mentioned earlier, activation of GPCRs coupled to 
Gα12/13 leads to the GDP/GTP exchange of the Gα subunit, dissociation of the Gβγ dimer 
and activation of the Gα12/13-dependent downstream cellular responses (Hepler and 
Gilman, 1992). Shortly after their discovery, the first report on Gα12/13-mediated signalling 
came from experiments in Drosophila melanogaster where it was shown that this group of 
G proteins induces contraction and migration of cells in the Drosophila embryo (Parks and 
Wieschaus, 1991). This was followed by the discovery of the Guanine Exchange Factors 
(GEFs) of Rho GTPases named RHOGEFs important for regulation G protein signalling 
specifically for  Gα12/13 (Fukuhara et al., 2001). The main purpose of RHOGEF proteins is 
to act as GTPase-Activating Proteins (GAPs) in order to accelerate G protein function (Xie 
and Palmer, 2007; Zhong and Neubig, 2001). So far, four types of RHOGEF proteins have 
been shown to be regulated by Gα12/13 proteins: p115-RHOGEF, PSD-95/Disc-Large/ZO-
1 Homology (PDZ)-RHOGEF, Leukemia-Associated RHOGEF (LARG) and Lymphoid 
Blast Crisis (Lbc)-RHOGEF. Activation of Gα12/13 leads to translocation of RHOGEFs 
from the cytosol to the plasma membrane, where they promote an active conformation of 
the small GTPase RHOA, by catalysing the GDP/GTP exchange. At the same time, the 
Regulators of G protein Signalling (RGS) domain of RHOGEF accelerates the hydrolysis 
of the Gα-bound GTP regulating the inactivation of the G protein as a part of a negative 
feedback loop (Dutt et al., 2004; Fukuhara et al., 2001; Meyer et al., 2008).  
  9 
RhoA regulates multiple downstream targets important for the cell cytoskeleton. By 
activating Rho Kinases (ROCK1 and 2), RhoA mediates processes such as actin stress 
fiber formation, activation of Serum Response Transcriptional Factor (SRF) and cell 
contractions (Narumiya et al., 1997; Riento and Ridley, 2003; Treisman et al., 1998). 
While RHOA activation is the most studied downstream signalling aspect, Gα12/13 are also 
reported to regulate a range of additional proteins. Type I and type II cadherins are some 
of these, where it has been shown that Gα12/13 can bind to the cytoplasmic tail of cadherins 
in order to inhibit their adhesive function and induce the release of β-catenin (Meigs et al., 
2001, 2002). The most striking phenotype, showing the importance of Gα12/13 family of G 
proteins, comes from studies performed on mice, where ablation of Gα12/13 coding genes 
leads to severe developmental defects, mainly due to undeveloped vasculature and 
haemorrhage (Offermanns et al., 1997a). In addition, ablation of Gα12/13 in glial and 
neuronal cells was shown to enhance migration of cortical neurons, while the specific 
ablation of Gα13 in platelets increased bleeding time in mice (Moers et al., 2003, 2008).  
Lately, the Hippo pathway has been suggested to be regulated by GPCRs and Gα12/13. 
By inactivating the activity of the transcriptional co-activators Yes Associated Protein 1 
(YAP) and Tafazzin (TAZ), the Hippo tumour suppressor pathway regulates processes 
like cell shape and polarity, cell adhesion and organ size (Piccolo et al., 2014; Yu et al., 
2012a). One of the processes where YAP/TAZ activity has been shown to be important is 
in regulation of endothelial vessel sprouting and junctional stability during angiogenesis 
(Choi and Kwon, 2015; Choi et al., 2015). Recently, it was shown that Lysophosphatidic 
Acid (LPA) and Sphingosine 1-Phospophate (S1P) are able to inhibit the Hippo signalling 
by activating YAP/TAZ transcriptional activity through activation of Gα12/13. Moreover, 
activation of YAP through the Protease Activated Receptor 1 (PAR1) GPCR was shown 
to act through activation of RHOA, leading to an increased assembly of F-actin (Regué et 
al., 2013; Yu et al., 2012a). Interestingly, activation of the two transcriptional co-activators 
YAP and TAZ has also been associated to WNT signalling, where activation of the 
pathway by WNT-5A/B and WNT-3A leads to the de-phosphorylation of YAP/TAZ and 
the subsequent activation through FZD/ROR/Gα12/13 signalling, independent of β-catenin 
(Park et al., 2015). In addition, the two Hippo pathway components YAP and TAZ have 
also been suggested to be a part of the β-catenin destruction complex (Azzolin et al., 
2014). 
 
1.2.3 Class FZD G protein-coupled receptors 
 
After the first cloning attempts of FZDs, it was clear that these receptors were 
membrane proteins comprising seven transmembrane helices and thus, belong putatively 
to the superfamily of GPCRs (Barnes et al., 1998; Fredriksson et al., 2003; Park et al., 
1994; Vinson et al., 1989; Wang et al., 2006). The first functional indication of FZDs 
being GPCRs came from experiments showing that WNT/β-catenin signalling was 
inhibited in F9 teratocarcinoma cells when treated with a toxin from Bordella pertussis 
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(PTX) known to ADP-ribosylate the Gαi/o proteins ( Birnbaumer et al., 1990; Liu et al., 
2001; Slusarski et al., 1997a).  
Following the initial studies, several groups started to report the importance of G 
proteins in WNT/FZD signalling. Studies performed in Danio rerio demonstrated that 
inhibition of G protein signalling blocked the changes of Ca
2+
 influx usually observed 
upon WNT-5A stimulation. This was followed by in vivo experiments demonstrating that 
FZDs act as GEFs for G-proteins, mediating both β-catenin and PCP signalling in 
Drosophila melanogaster (Katanaev et al., 2005; Slusarski et al., 1997b, 1997c). Adding 
to the proof, it was shown that FZD2 could induce the release of Ca
2+
. The creation of a 
chimeric receptor with partial segments of FZD2 and the β2-adrenergic receptor, 
demonstrated that FZD2 could signal through modulation of Cyclic Guanosine 3’,5-Mono-
Phosphate (cGMP) and that FZD2 induced Ca
2+
 transients that could be reduced by 
phosphodiesterase, suggesting G protein-dependent Ca
2+
 signalling. Moreover, stable 
transfection of the chimera in F9 embryonic teratocarcinoma cells, showed that FZD2-
induced Ca
2+
 transients required two Pertussis Toxin-sensitive G proteins, Gαo and Gαt 
(Ahumada et al., 2002; Liu et al., 1999). Recently, it was shown that WNT-7B and WNT-
3A regulate osteoblastogenesis by the regulation of transcriptional activity through Gαq 
and PKCδ-dependent signalling (Tu et al., 2007). Another G protein shown to be involved 
in WNT/FZD signalling is Gα11. By mediating WNT-11/FZD7 signalling Gα11 was shown 
to have a function in regulation of DVL phosphorylation and plasma membrane 
recruitment as well as the regulation of convergent extensions in Xenopus (Iioka et al., 
2007). Under basal conditions FZD9 was found to be pre-coupled to Gαo, a state from 
which Gαo could dissociate upon WNT-5Astimulation. In the postsynaptic region, this 
receptor was found to mediate the increase in spine density. By inhibiting G protein 
signalling, particularly Gαo,WNT-5A was shown to be the controlling factor driving the 
process of spine density (Ramírez et al., 2016). Moreover, the PCP pathway was recently 
shown to be important for the repair of skeletal muscles. WNT-7A/FZD7-induced 
activation of PCP leads to symmetric expansion of satellite cells enhancing the damage 
repair by activating the Akt/mTor pathway. Gαs and PI(3K) are some of the crucial 
components required for myotube growth induced by Akt/mTor. Both Gαs and PI(3K) 
were shown to be associated with FZD7 in a complex (von Maltzahn et al., 2012). 
Several publications from our group are supporting the growing evidence that FZDs are 
able to employ heterotrimeric G proteins to transduce signalling cues. In primary 
microglia, both WNT-3A and WNT-5A are important in the regulation of pro-
inflammatory responses. These responses were mediated through PTX sensitive Gαi/o 
proteins, important for both β-catenin-dependent and -independent signalling (Halleskog 
and Schulte, 2013; Halleskog et al., 2012). WNT-5A was also shown to induce the 
GDP/GTP exchange of Gαi/o proteins in N13 mouse microglia-like cells (Kilander et al., 
2011). Furthermore, FZD6 was shown to be associated in an inactive state complex with 
Gαi and Gαq. Stimulation with WNT-5A dissociated the complex and induced DVL-
dependent phosphorylation of the Extracellular Signal-Regulated Kinase1/2 (ERK1/2) 
(Kilander et al., 2014a). 
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As we are just starting to understand the true nature of FZDs it is encouraging that 
several reports support the theory of FZDs being GPCRs. However, many questions still 
remain to be answered and research is limited by a lack of techniques that can be used. For 
that reason, it is important to continue the work on elucidating the mechanisms of these 
receptors with the hope that the future will bring a better and more comprehensive 
understanding of the WNT pathway.  
 
1.3 VASCULAR DEVELOPMENT OF THE CENTRAL NERVOUS SYSTEM 
 
1.3.1 Blood-brain barrier formation 
 
Development and homeostasis of the central nervous system (CNS) depends on the 
delivery of nutrients and oxygen from specialized blood vessels. Unique features of the 
CNS vasculature are not only the contribution to its proper function, but also serve to 
shield and protect the CNS from possible pathogens and toxic agents. Joined by 
continuous tight junctions, the endothelial cells of the blood-brain barrier (BBB) create a 
physical barrier between the blood and the brain parenchyma. At the same time, these 
unique cells express a selection of proteins like transporters and ion pumps in order to 
provide the brain with crucial nutrients such as glucose (Blanchette and Daneman, 2015; 
Engelhardt and Liebner, 2014; Paolinelli et al., 2011; Zhao et al., 2015). Tight junctions 
are composed of proteins like claudins and zonula occludens and create polarized cells 
with distinct abluminal and luminal membrane composition. Adherence junctions are 
found on the abluminal side of the blood vessels and are linked with tight junctions. They 
consist of proteins like VE-Cadherins which are important for the regulation of cell 
adhesion by binding the actin cytoskeleton via catenins (Brightman and Reese, 1969; 
Huber et al., 2001; Reese and Karnovsky, 1967; Rubin and Staddon, 1999).  
Since the developing CNS originates from ectoderm germ layer that is devoid of 
vascular progenitor cells, it is dependent on invasion of blood vessels from the 
surrounding mesoderm.  In the mouse, the invasive process of CNS blood vessel 
development begins with vasculogenesis at the embryonic stages E7.5-E8.5. Here, the 
mesoderm derived endothelial precursor cells named angioblasts assemble outside of the 
brain in order to form a simple vascular network the perineural vascular plexus (PNVP). 
This is followed by the sprouting process of angiogenesis at around E9.5 where new blood 
vessels are formed from pre-existing blood vessels by radially invading the brain in a 
spatio-temporal manner forming the perivascular plexus (PVP). Angiogenesis is guided by 
endothelial tip cells that, with the help of their numerous filopodia, sense and guide the 
vascular sprouts into the brain and promote fusion with adjacent endothelial cells. 
Following the endothelial tip cells, the stalk cells create the vascular lumen by 
proliferation (Fig.4). As a final step of CNS vascular development, the blood vessels 
become associated with surrounding cells like pericytes, microglia and astrocytes for 
stabilization and regulation of vessel perfusion (Bentley et al., 2009; Engelhardt, 2003; 
Franco et al., 2009; Mancuso et al., 2008; Potente et al., 2011). During all developmental 
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stages of the BBB, a plethora of cellular and acellular cues direct the CNS endothelial cell 
to acquire their characteristic BBB features (Blanchette and Daneman, 2015; Engelhardt 
and Liebner, 2014; Risau, 1997).  
Multiple signalling pathways regulate blood vessel development. Besides the WNT 
pathway that will be discussed in the following section, some of the others include 
Vascular Endothelial cell Growth Factor (VEGF), Platelet-Derived Growth Factor 
(PDGF), Transforming Growth Factor (TGF) and Notch signalling. VEGF is produced by 
the neural progenitors and together with its tyrosine kinase receptors VEGFR1 and 
VEGFR2, it is responsible for inducing the invasion of blood vessels from the PNVP and 
for regulating branch patterning during angiogenesis (Raab et al., 2004). While VEGF 
signalling is the driving regulator of sprouting and branching, Notch signalling exerts the 
opposite effect.  Depletion of the Notch receptor and its ligand leads to enhanced 
sprouting, vessel branching and fusion (Adams and Alitalo, 2007).  PDGF-β is produced 
by the migrating endothelial cells. The main responsibility of this protein is to attract 
pericytes to the developing vasculature. Ablation of  the PDGF-β ligand or receptor leads 
to a lack of pericyte recruitment and lethal microaneurisms (Lindahl et al., 1997). Also 
ablation of the TGF-β ligand or receptor leads to a severe vascular phenotype indicating 
the importance of this pathway for proper development of the blood vessels (Adams and 
Alitalo, 2007) 
 
 
 
                                                Mouse embryo at E11.5 
 
Figure 4: Simplified illustration displaying the sprouting process of mouse forebrain angiogenesis. In mice, 
vascularisation of the brain begins with the formation of the simple perineural vascular plexus (PNVP) 
outside of the brain. This is followed by the invasion of radially sprouting blood vessels into the brain that 
sequentially form the more complex vascular network named perivascular plexus (PVP). (forebrain (FB), 
midbrain (MB) and hindbrain (HB)). 
 
1.3.2 WNT/FZD signalling in angiogenesis 
 
WNT proteins are morphogens and can act in a gradient-dependent manner as long- or 
short-range cues deciding the fate of cells during embryonic development. WNT 
signalling, and in particular the β-catenin-dependent pathway, has been reported to be 
crucial for proper vascular development of the CNS. Important for formation, 
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differentiation and maintenance of the BBB, β-catenin activity has been shown to be 
strong in the blood vessels penetrating the brain during angiogenesis (Daneman et al., 
2009; Dejana, 2010; Liebner and Plate, 2010; Stenman et al., 2008). Playing a dual role as 
both a structural component of adherence junctions and a transcriptional activator, β-
catenin ablation causes severe haemorrhage throughout the entire CNS. Moreover, 
ablation of two neuroepithelial derived WNT ligands, WNT-7A and WNT-7B showed an 
almost identical phenotype, with low expression of the glucose transporter Glut-1 and 
haemorrhage indicating that these two FZD agonists were crucial for vascular 
development of the CNS (Daneman et al., 2009; Engelhardt, 2003; Liebner et al., 2008; 
Stenman et al., 2008; Zhou and Nathans, 2014; Zhou et al., 2014a). In addition to WNT-
7A and WNT-7B ablation, it was recently shown that endothelial cell specific knock out of 
the G Protein-Coupled Receptor 124 (GPR124), believed to be a co-activator of WNT-7A 
and WNT-7B, resulted in the abnormal development of the blood vessels in the forebrain 
and spinal cord (Zhou and Nathans, 2014). FZD4 is by far the best studied WNT receptor. 
Loss-of-function of this receptor is often related to vascular defects and complete ablation 
of FZD4 results in increased permeability of the BBB. Strengthening the importance of 
this receptor in CNS blood vessel development is the phenotype observed in mice where 
the FZD4-specific ligand Norrin is removed. Genetic ablation of Norrin in mice causes 
severe defects in the retinal vasculature and leakiness of the BBB (Junge et al., 2009; Paes 
et al., 2011; Smallwood et al., 2007; Wang et al., 2012; Ye et al., 2009).   
While the importance of proper β-catenin signalling in blood vessel development has 
been studied to a larger extent, there are several reports showing the need for β-catenin-
independent signalling. β-catenin-independent signalling in endothelial cells is most often 
associated with endothelial cell migration, cell proliferation, cell growth and vessel 
sprouting. In cell culture assay, inhibition of the PCP pathway resulted in disrupted 
processes such as cell migration, cell polarity and cell growth implicating the need for 
PCP signalling in vascular development and remodelling. Moreover, experiments 
performed on embryonic stem cells lacking WNT-5A indicated that this FZD ligand was 
important for both PKC and WNT/β-catenin-dependent vascular development (Cirone et 
al., 2008; Yang et al., 2009). 
The essential requirement for WNT signalling during blood vessel development and 
maintenance has been supported by several studies over the years where both β-catenin-
dependent and -independent signalling play an important role. However, considering the 
complexity of this pathway with 19 ligand homologues and 10 receptors, more needs to be 
done in order to have a comprehensive view on how exactly WNT signalling is regulating 
the blood vessel development and BBB integrity (Cheng et al., 2008; Cirone et al., 2008; 
Engelhardt and Liebner, 2014; Goodwin et al., 2007; Masckauchán et al., 2006; Pinzón-
Daza et al., 2014; Yang et al., 2009; Zerlin et al., 2008). 
 
1.3.3 Role of matrix proteins during brain vascularization 
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While it has been established that signalling by growth factors such as WNT proteins, 
VEGF, TGFβ and PDGFβ is essential for the vascularisation (Adams and Alitalo, 2007; 
Engelhardt and Liebner, 2014), recent studies have focused on the need for extracellular 
matrix proteins in regulation of blood vessel development and maintenance. Secreted by 
the endothelial cells, pericytes and astrocytes extracellular matrix proteins such as 
collagens, laminins and fibronectin provide structural support for blood vessels and act as 
regulators of vessel permeability and scaffolds for growth factors (Blanchette and 
Daneman, 2015; Correale and Villa, 2009). Deregulation of matrix proteins has been 
implicated in the leakiness of the BBB as well as diverse disorders such as stroke and 
Alzheimer's disease (Baeten and Akassoglou, 2011; Ding et al., 2009; Engelhardt and 
Liebner, 2014).  
An important group of matrix proteins are the extracellular metalloproteinases 
including Matrix Metalloproteinases (MMPs) and A Disintegrin And Metalloproteinase 
(ADAM) proteins. MMPs act mostly on the cell surface where they control activation of 
signalling molecules, but they are also crucial for the regulation of BBB permeability by 
acting on basal lamina and endothelial tight junctions. Families of ADAM and A 
Disintegrin And Metalloproteinase with Thrombospondin Motifs (ADAMTS) proteins 
have been reported to be both pro- and anti-angiogenic. While ADAM proteins have been 
shown to support vessel sprouting, intracellular signalling and cell adhesion, they are also 
able to act as inhibitors by sequestering growth factors such as VEGF and TGFβ (Le Goff 
et al., 2008a; Rodríguez-Manzaneque et al., 2015; Rosenberg, 2009). 
 
1.3.4 Gα12/13 signalling in angiogenesis 
 
The very first studies performed on mice where Gα12 and Gα13 were ablated 
demonstrated the importance of these proteins for vascular development. While single 
mutants lacking Gα12 are viable and appear normal, mice lacking Gα13 die at E9.5 as a 
result of severe defects in angiogenesis. Moreover, when introducing a one allele mutation 
of Gα13 to the viable Gα12-deficient mice, premature death occurs as a consequence in 
utero. In addition, double knock-out mice lacking both Gα12 and Gα13 die at the embryonic 
stage E8.5 as a result of impaired vascular development (Gu et al., 2002; Offermanns et 
al., 1997b). Studies have shown that the vascular defects observed in Gα13-deficient mice 
depend on the absence of the Gα subunit specifically in endothelial cells. By cell specific 
ablation of Gα13 in the vascular cells, Ruppel et al. could show that transgenic 
overexpression of Gα13 in endothelial cells could rescue the vascular phenotype (Ruppel et 
al., 2005). More recent studies performed on cells derived from Gα13-deficient mice, 
indicate that Gα13 signalling is important for the regulation of endothelial cell shape and 
movement given that isolated Gα13-deficient vascular cells fail to form a network and 
tubes in cell culture (Worzfeld et al., 2008). Another study showed that Gα13 mediated 
angiogenesis by stimulating the transcriptional activity of Myocyte Enhancer Factor 2 
(MEF-2). Downregulation of either Gα13 or MEF-2 causes a decrease in endothelial cell 
proliferation. In cells where Gα13 was downregulated, the proliferative activity could be 
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rescued by constitutively active MEF-2 (Liu et al., 2009). Gα13 has also been shown to be 
important for the regulation of endothelial VEGF Receptor-2 (VEGFR-2) expression 
given that reduced levels of the receptor were observed in sites of angiogenesis upon cell 
specific ablation of Gα13. Depletion of Gα13 results in a reduced response to VEGF-A in 
endothelial cells. However, the sensitivity to VEGF-A could be restored upon 
normalization of the receptor levels. Here the VEGFR-2/Gα13-mediated signalling in 
vascular cells is believed to be regulated through activation of RHOA and subsequent 
induction of NFκB transcriptional activity (Sivaraj et al., 2013).  
Understanding the mechanisms that regulate CNS vascular development opens up the 
possibilities for creating better treatments for severe disorders such as cancer and stroke. 
Due to the special characteristics of the BBB, it is not only protecting the brain from 
pathogens, but is also preventing administration of pharmaceuticals necessary for 
treatment. On the other hand, in disease states like stroke it would be of interest to 
regenerate the barrier features. For these reasons, understanding the underlying 
mechanisms of CNS blood vessel development is of crucial importance.  
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2 SPECIFIC AIMS 
 
1. To develop a more in depth understanding of the role of WNT signalling in CNS-
specific blood vessel development. 
2. To identify the FZDs expressed during CNS angiogenesis and their role as GPCRs. 
3. To determine the G protein partner(s) of FZD4 and relevant pathways that become 
activated. 
4. To define expression of FZD10 in the developing brain, the G protein(s) it couples to 
and downstream signalling events. 
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3 MATERIAL AND METHODS 
 
3.1 FLUORESCENT RECOVERY AFTER PHOTOBLEACHING 
 
Fluorescent recovery after photobleaching (FRAP) was developed to study binding 
dynamics and diffusion in live cells. Considering that more conventional binding assays 
are difficult to apply to the studies of FZDs, we took advantage of this technique in order 
to define the G protein partners of FZD4 and FZD10. The FRAP protocol used was 
modified as double-colour (dc)-FRAP, described previously by our group and others 
(Dorsch et al., 2009; Kilander et al., 2014b; Qin et al., 2008, 2011; Reits and Neefjes, 
2001).  
For the purpose of defining FZD/G protein partners, we used fluorescently-tagged 
receptors and Gα subunits. The FRAP measurements are assessed by irreversible 
photobleaching of a small defined area, followed by measurement of the subsequent 
diffusion of fluorescent proteins entering the bleached region. While the bleaching is 
performed with a high intensity laser, the recovery of the fluorescence is measured with 
low laser power.  
After setting the base line of physiological conditions, we chemically cross-linked the 
surface of the cells through the addition of sulfo-NHS-LC-LC-biotin and avidin, which 
efficiently immobilizes only the membrane proteins. Measuring the fluorescent recovery 
of FZDs and G proteins before and after cross-linking, we could identify the Gα subunits 
with affected diffusion kinetics after immobilization of the receptor (Fig.5). 
 
 
 
 
Figure 5: Illustration of FRAP measurements. A restricted area is bleached with high laser power and the 
fluorescence intensity is measured over time. Initially, the fluorescence decreases but recovers by the 
diffusion of molecules into the bleached area. By comparing the fluorescence intensity after recovery to the 
intensity before and just after bleaching, the mobile fraction can be calculated. Scale bar 5µm.  
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By comparing with the Gα subunits of all four families of G proteins, we identified the 
group of Gα12/13 as interaction partners of FZD4 and FZD10 in forming an inactive-state 
complex. While GPCRs are able to signal to G proteins both through collision-coupling 
and through inactive-state preassembly, dcFRAP can only be used for identifying proteins 
in the inactive-state complex (Hein et al., 2005; Neubig, 1994; Oldham and Hamm, 2008; 
Qin et al., 2011). In comparison to the more conventional Förster resonance energy 
transfer (FRET) method, dcFRAP is rather affinity based than proximity based. Thus, our 
data argue that the complex formed between the receptor and G protein is formed through 
physical interaction.   
 
3.2 FÖRSTER RESONANCE ENERGY TRANSFER 
 
Förster resonance energy transfer (FRET) is a technique for the determination of 
molecular proximity. FRET is referred to as the process where energy is transferred from 
one excited molecule called a donor, to another molecule called an acceptor. In order for 
FRET to occur, the two fluorescently tagged molecules need to interact with close 
proximity, with a distance less than 10nm. Also relative dipole moments between the 
donor and the acceptor caused by fluorophore orientation can affect FRET. A variant of 
FRET that is used on fixed cells, where the specimen can serve as its own control, is 
known as acceptor photobleaching FRET. Here, the fluorescence intensities of the donor 
are measured before and after bleaching, of a small limited area. Since energy transfer 
reduces the donor fluorescence, the intensity of the donor will increase upon bleaching of 
the acceptor (Fig.6) (Ishikawa-Ankerhold et al., 2012).  
In Paper II, we employed acceptor photobleaching FRET in fixed cells in order to 
confirm that stimulation of the receptor with WNT-7A leads to dissociation of the 
inactive-state complex formed with Gα12/13. If the Gα12/13 and FZD4 formed a complex as 
shown by the dcFRAP experiments, they would have a basal FRET. Stimulation of the 
receptor would lead to dissociation of the Gα12/13 and a reduction in FRET thereby 
resulting in an increase of the fluorescence intensity of the donor. As seen from the results 
in Paper II, this indeed was the case confirming the data generated by the dcFRAP method 
that revealed an interaction between FZD4 and Gα12/13.   
 
 
 
Figure 6: Illustration of FRET measurements. Only close proximity between fluorescently tagged donor and 
fluorescently tagged acceptor can induce FRET.  
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3.3 DYNAMIC MASS REDISTRIBUTION 
 
Dynamic mass redistribution (DMR) assay is a technique developed to study ligand-
induced responses as a complement to more classical end point assays giving a more 
comprehensive pharmacological estimate of the entire living cell. Given that DMR is a 
label-free, non-invasive assay, it can be applied to diverse cellular systems. Allowing for 
the possibility to measure various cellular responses such as receptor internalization, 
cytoskeletal rearrangements, adhesion and protein trafficking, DMR has been used to 
measure the effect of activation of receptors associated to all four G protein subfamilies, 
but also to detect concentration dependent cellular changes for a number of GPCRs 
(Antony et al., 2009; Grundmann and Kostenis, 2015; Schröder et al., 2010, 2011).  
In order to measure DMR, cells are seeded on biosensor microplates and exposed to 
polarized broadband light that illuminates the bottom of the plate. At the bottom an optical 
system is formed by interacting cells and the biosensor with wavelength grating. This 
system spreads and reflects specific wavelength that is in resonance while the others are 
transmitted. Depending on the Optical Density (OD) of the cell layer covering the grating, 
the resonance is defined and the alterations in the reflection index can be detected. The 
addition of a compound like an agonist to the cells, leads to fluctuations in the OD as a 
result of changes in the cell shape or redistribution of intracellular molecules. This causes 
a shift of the outgoing wavelength in comparison to baseline. If the treatment of cells leads 
to an increase of the outgoing wavelength as a result of an increased OD, it is measured as 
a positive signal over time, while a decrease in OD and a decrease in the outgoing 
wavelength is measure as a negative signal over time (Fig.7) (Schröder et al., 2011).  
 
 
 
 
Figure 7: Illustration of DMR measurements. A cell is exposed to polarized broadband light that illuminates 
the bottom of the biosensor plate. Wavelength in resonance is reflected and used for calculating OD 
dependent reflexion index while the wavelengths that are not in resonance are transmitted.  
 
Applying this technology on wild type and Gα12/13 knock-out cells, we concluded that 
cells expressing FZD4 and FZD10, when stimulated with an agonist such as WNT-5A, 
could induce a negative DMR signal. This signal was achieved only in cells where Gα12/13 
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were present, indicating that these two receptors provoke G12/13-dependent cellular 
changes.  
 
3.4 P115-RHOGEF RECRUITMENT ASSAY  
 
While studying the activation of FZDs is difficult, investigating the activation of Gα12/13 
is equally as challenging. Of the four families of G proteins, the subfamily of Gα12/13 is the 
least defined and novel tools for measuring the activation of these proteins are still being 
developed. In order to assess whether FZD4 and FZD10 activate Gα12/13 signalling we took 
advantage of the p115-RHOGEF recruitment assay (Meyer et al., 2008).  
P115-RHOGEF has multiple roles in Gα12/13 signalling. It acts as a Guanine Exchange 
Factor (GEF) on the small GTPases like RHOA, but it also contains domains like the 
pleckstrin homology (PH) domain, which is important for the subcellular localization and 
full exchange activity. Though p115-RHOGEF is a GEF for RHOA, it also comprises an 
RGS domain for the hydrolysis of the Gα-bound GTP to GDP, inactivating the G protein.  
In order to asses G protein activation of FZD4,we used the techniques published by 
Mayer et al. which showed that co-expression of constitutively active Gα12/13 induce a 
translocation of EGFP-tagged p115-RHOGEF protein from the cytosol to the membrane-
anchored GTP-bound Gα12/13 (Fig.8). By co-expressing fluorescently-tagged FZD4 with 
Gα12/13, p115-RHOGEF and untagged βγ subunits, we could demonstrate that the presence 
of the receptor resulted in the translocation of p115-RHOGEF to the membrane indicating 
that Gα12/13 subunits were activated and GTP-bound.  
 
 
 
Figure 8: Transient expression of p115-RHOGEF-GFP in the absence and presence of GTP-bound, 
constitutively active Gα13. This image shows that activation of Gα13 leads to the translocation of p115-
RHOGEF from the cytosol to the plasma membrane. Scale bar 10µm. 
 
We also extended this technique by co-expressing the RGS domain of the p115-
RHOGEF, which is catalysing the hydrolysis of the Gα subunit and promoting its 
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inactivation. Addition of this component reduced the membranous location of p115-
RHOGEF and confirmed that Gα12/13 was indeed activated by FZD4.   
 
4 RESULTS AND DISCUSSION  
 
4.1 WNT SIGNALLING IN VASCULAR DEVELOPMENT 
 
4.1.1 AXIN1 overexpression as a new model-system to study CNS Angiogenesis 
(Paper I) 
 
The importance of β-catenin in vascular development, blood-brain barrier 
formation and maintenance has been well established in the past decade (Cattelino et al., 
2003; Daneman et al., 2009; Stenman et al., 2008). However, a dual role for β-catenin as 
both a structural element of adherence junctions and as a transcriptional activator hinders 
the selective modulation of only one of these pools. This, in turn, has made it more 
difficult to dissect out if the vascular phenotype caused by β-catenin ablation is a result of 
mainly downregulation of its transcriptional activity or its absence in adherence junctions 
(Cattelino et al., 2003; Liebner and Plate, 2010; MacDonald et al., 2009b; Peifer et al., 
1992). Moreover, the severe vascular phenotype observed upon deletion of β-catenin does 
not allow for a more detailed analysis of the cause of haemorrhage. Is the compromised 
BBB caused by the inability of the cells to form vascular networks, is it caused by 
downregulation of junctional proteins or is it caused by the inability of endothelial cells to 
attract supporting cells like pericytes and microglia? 
By developing a new mouse model where AXIN1, the major component of the β-
catenin destruction complex, is specifically expressed in endothelial cells and at specific 
time points by Cre-mediated recombination, we were able to conditionally modulate the β-
catenin levels. Moreover, it allowed us to analyse the developing brain vasculature on both 
cellular and gene expression levels in detail by generating a mild overexpression of 
AXIN1. In addition, by targeting AXIN1, the issue of affecting the junctional β-catenin is 
somewhat circumvented. 
Inducing endothelial-specific AXIN1 overexpression at early embryonic stages by 
tamoxifen leads to forebrain haemorrhage after 4 days. The embryos display a highly 
disorganized and immature vasculature similar to other WNT pathway mutants. 
Furthermore, by crossing the AXIN1 mutant with WNT reporter mice we were able to 
confirm downregulation of β-catenin transcriptional activity in brain endothelium at 
E11.5, two days after AXIN1 induction. In addition, RNA-sequencing on isolated brain 
endothelial cells from the same stage confirmed that AXIN1 inhibited β-catenin since 
known β-catenin downstream target genes like Adenomatosis Polyposis Coli 
Downregulated 1 protein (Apcdd1) and Transcription Factor (Tcf7) were downregulated.  
Moreover, transporters such as Solute carrier family 2, facilitated glucose transporter 
member 1 (SLC2A1 or Glut-1) were downregulated, while the junctional proteins like 
occludin (OCLN) and claudin5 (CLDN5) were differentially regulated. The RNA 
sequencing data also provided us with an overview of WNT receptors present in the 
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developing BBB at E11.5 when angiogenesis is highly ongoing (Fig.9), but also helped us 
to identify new WNT/β-catenin downstream proteins. By analysing mouse embryonic 
whole-mount brain samples before the haemorrhage occurs at E11.5 and when tamoxifen 
was administrated at either E9.5 or E10.5, we observed that downregulation of β-catenin 
led to increased vascular regression and remodelling. This was illustrated, for example, by 
an increased number of retracted vessel sprouts, increased blood vessel diameter and 
decreased number of branch-points.  
Combining different techniques and developing a novel mouse model enabled us to 
study the role of β-catenin in the formation of BBB in more detail. While it could be 
assumed that the haemorrhage of the CNS vasculature occurs as a result of a disrupted 
BBB, leaking vessels and reduced recruitment of other cell types, our analysis showed that 
the main reason is due to immediate retraction of newly formed vessel sprouts. 
 
G
e
n
e
 e
x
p
re
s
s
io
n
 (
R
P
K
M
)
fz
d1
fz
d2
fz
d3
fz
d4
fz
d5
fz
d6
fz
d7
fz
d8
fz
d9
fz
d1
0
0
5
10
15
20
25
 
Figure 9: Graph illustrating gene expression levels of all ten FZDs in brain endothelial cells at E11.5.   
 
4.1.2 Interplay between WNT/FZD signalling and other pathways in BBB 
development (Paper I) 
 
After the identification of the process leading to haemorrhage, we investigated our 
RNA sequencing data in order to identify possible candidates that might be acting 
downstream of β-catenin. Extracellular matrix proteins are a group of proteins that are less 
studied in the context of BBB development, but where more evidence is accumulating, 
demonstrating their role in proper vascular development. Some of the processes where 
extracellular matrix proteins play a role are blood vessel remodelling and maturation 
(Baeten and Akassoglou, 2011). Among the genes in the RNA sequencing data, 
ADAMTS-Like Protein 2 (ADAMTSL2) was one such extracellular matrix protein 
identified as the best candidate with high expression levels under normal conditions and 
strong downregulation upon AXIN1 overexpression. In contrast to other ADAMTS 
proteins, ADAMTSL2 lacks protease activity, but still preserves its adhesive function. As 
a secreted extracellular matrix protein ADAMTSL2 regulates the bioavailability of TGFβ 
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through binding to Latent TGFβ Binding Protein1 (LTBP1) (Koo et al., 2007; Le Goff et 
al., 2008b).  
In order to study the role of ADAMTSL2, we used the zebrafish model system where 
we started with identifying the presence of ADAMTSL2 through antibody detection. 
Immunohistochemistry showed us that ADAMTSL2 readily expressed in the zebrafish 
embryo 24 hours post fertilization (hpf) and that the expression became more pronounced 
in the head at 72 hpf. Injection of AXIN1 mRNA led to reduced protein levels of 
ADAMTSL2. Moreover, AXIN1 overexpression induced a mild defect of the head and a 
dramatic reduction in central artery density at 72 hpf. Both β-catenin and ADAMTSL2 
could rescue the vascular phenotype caused by AXIN1. In addition, downregulation of 
ADAMTSL2 with morpholino led to reduced ADAMTSL2 protein levels and vascular 
defects that were rescued by co-injection with ADAMTSL2 mRNA.  
Previously, it was shown that ADAMTSL2 regulates the level of TGFβ (Le Goff et al., 
2008a). We tested whether ADAMTSL2 knock-down in endothelial cells would lead to 
increased TGFβ signalling. Indeed, downregulating of ADAMTSL2 in human umbilical 
vein endothelial cells (HUVECs) resulted in a significant increase in phosphorylation of 
Mothers Against Decapentaplegic Homolog 3 (SMAD3), the transcriptional activator of 
TGFβ signalling. To test the hypothesis that the CNS vascular malformation depends on 
increased TGFβ signalling, we administrated small molecule inhibitors of this pathway to 
AXIN1 overexpressing mice. This treatment partially reduced the vascular phenotype 
where the main effect was seen in decreased levels of dilated vessels. On the other hand, 
the vascular phenotype caused by ADAMTSL2 knock out in zebrafish was completely 
rescued by treatment with TGFβ inhibitors.  
In conclusion, in Paper I, we show that β-catenin regulates CNS blood vessel 
development by controlling the vascular remodelling. Moreover, we identify ADAMTSL2 
as a β-catenin downstream protein mediating the crosstalk between WNT/β-catenin and 
TGFβ signalling, during BBB formation and maturation.  
 
4.2 FRIZZLEDS AS G PROTEIN-COUPLED RECEPTORS 
 
Ever since the discovery of FZDs, their role as GPCRs has been questioned. However, 
accumulating structural and mechanistic data is supporting their classification in the class 
Frizzled GPCRs (Foord et al., 2005; Halleskog et al., 2012; Kilander et al., 2011, 2014a; 
Lagerström and Schiöth, 2008; Schulte, 2010) together with Smoothened.  As a 
consequence of the long debate, the field of β-catenin-independent and G protein-mediated 
WNT signalling has developed with slower haste. In addition, the development of 
necessary tools to study WNT-induced G protein signalling is lagging behind. The fact 
that numerous combinations of interactions between the ten receptors and 19 ligands exists 
and that majority of cells express several FZDs makes it even more complex to study G 
protein activation of one selective receptor. The situation becomes more complex when 
considering that no pharmacologically defined ligands or small molecules exist that could 
be used to study WNT signalling in a FZD-isoform-selective manner, while the 
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commercially available recombinant WNTs suffer from instability and potential impurities 
with signal activity (Cajanek et al., 2010). 
 
4.2.1 FZD4 forms an inactive state complex with Gα12/13 (Paper II) 
 
While it is well established that FZD4 can signal to β-catenin and that it is important for 
vascular development (Wang et al., 2012; Zhou et al., 2014b), little is known about the 
role of FZD4 as a GPCR. In Paper II, we used the double-colour FRAP method in 
combination with surface crosslinking of the receptor, in order to show that FZD4 is able 
to form an inactive state complex with Gα12 and Gα13, but no other representatives of the 
Gα subfamilies. This was illustrated by a reduction of the mobile fraction of G proteins, 
caused only by a physical interaction between the crosslinked receptor and the G protein. 
Moreover, we could demonstrate that stimulation of the receptor with WNT-3A, WNT-
5A, WNT-7A and WNT-10B could dissociate the complex with Gα12 or Gα13. In line with 
the dcFRAP data, our results using FRET measurements show that WNT-7A stimulation 
leads to decreased energy transfer between FZD4 and Gα12/13 compared to baseline. 
Furthermore, by using the pan DVL siRNA and overexpressing the three different DVL 
isoforms, we could confirm that the formation of the inactive-state complex between FZD4 
and Gα12/13 was independent of DVL.  
In conclusion, in this study we identify for the first time that a WNT receptor is able to 
form a complex with the proteins of the Gα12/13 subfamily. In addition, we show that this 
complex formation is independent of the phospho-protein DVL and that stimulation by 
WNTs dissociates the Gα12/13 from FZD4.  
 
4.2.2 FZD4-mediated G protein signalling (Paper II) 
 
In order to dissect out if the inactive-state assembly and dissociation leads to Gα12/13 
activation, we employed DMR a technique that is able to detect ligand-induced cell 
changes in live cells. In cells, DMR can be triggered by cellular processes like cytoskeletal 
rearrangements and adhesion known to be connected to Gα12/13 signalling (Schröder et al., 
2011; Worzfeld et al., 2008). Using DMR measurements on wild type and Gα12/13 knock-
out cells, we conclude that that stimulation of wild type cells with WNT-5A induced 
negative DMR when FZD4 was over-expressed. In addition, the negative DMR was absent 
in cells where Gα12/13 was ablated. Therefore, we were able to show that the DMR 
response observed in wild-type cells depends on both FZD4 and Gα12/13. 
To further assess the FZD4-dependent and Gα12/13-mediated downstream events and to 
confirm that FZD4 initiate the GDP/GTP exchange of Gα12/13 we performed the p115-
RHOGEF recruitment assay. P115-RHOGEF is an RGS for the Gα12/13 group of G 
proteins, binding specifically to the GTP form of the Gα subunit. Activation of Gα12/13 
leads to recruitment of p115-RHOGEF to the plasma membrane and the GTP-bound 
protein (Hart et al., 1998; Meyer et al., 2008). Overexpression of fluorescently-tagged 
FZD4, Gα12/13 and p115-RHOGEF illustrated that FZD4 induced the translocation of p115-
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RHOGEF to the membrane, to the same extent as the Lysophosphatidic Acid 1 receptor 
(LPA1 receptor) known to signal through Gα12/13 (Mutoh et al., 2012). This indicates that 
this receptor not only binds to Gα12/13, but also induces the GDP/GTP exchange and G 
protein activation. In contrast, the p115-RHOGEF membranous localization was not 
present in samples where Gα12/13 or FZD4 was absent. In cell culture, endogenous secretion 
of WNTs is constantly present. In order to evaluate the ligand-dependent p115-RHOGEF 
recruitment, we treated our cells with the porcupine inhibitor C59. This treatment leads to 
reduction of WNT protein production and endogenous WNT signalling (Dodge et al., 
2012; Galli et al., 2007). In concert with the observed data of inhibited LPA1 signalling 
with the LPA1 receptor-specific antagonist Ki16425 (Ohta et al., 2003), treatment of 
FZD4/Gα12/13 overexpressing cells led to reduced recruitment of p115-RHOGEF.  
Finally, to confirm the functionality of FZD4/Gα12/13-mediated signalling to p115-
RHOGEF, we introduced the RGS-domain of p115-RHOGEF. p115-RHOGEF binds to 
the active GTP-bound Gα12/13 and utilizes RGS activity on the Gα subunit as a feedback 
loop inactivating the signalling (Kozasa et al., 1998). By co-transfecting the domain of 
p115-RHOGEF accelerating the hydrolysis of GTP back to GDP, the RGS-domain, in 
combination with FZD4, Gα12/13 and p115-RHOGEF, we could decrease the recruitment of 
p115-RHOGEF to the plasma membrane.  
Altogether, the findings in Paper II show for the first time that FZD4 is a GPCR capable 
of mediating signalling through the Gα12/13/p115-RHOGEF axis.  
 
4.2.3 FZD10 selectively interacts with Gα13 (Paper III) 
 
While FZD4 was able to form an inactive-state complex with both Gα12 and Gα13, 
FZD10 was only capable of interacting with Gα13. Isoform selective signalling by the 
family of Gα12/13 proteins has been observed before, for example, in the case of stress fiber 
formation (Gohla et al., 1999). Moreover, stimulation of the inactive-state complex with 
WNT-5A and WNT-7A dissociated Gα13 from FZD10 as seen by dcFRAP measurements. 
On the contrary, stimulation with WNT-3A did not lead to an increase in the mobile 
fraction of the complex. These data indicate that FZD10 has a selective preference for 
specific G proteins and specific FZD ligands.  
In the case of FZD4, we showed that DVL was dispensable for FZD4-mediated Gα12/13 
signalling, while in the case of FZD6, the G protein interaction was sensitive to both low 
and high DVL levels (Arthofer et al., 2016; Kilander et al., 2014a). Assessing the 
importance of DVL for FZD10-mediated signalling, we performed dcFRAP experiments in 
the presence and absence of the phospho-protein. Data obtained from dcFRAP 
measurements in DVL1/2/3 knock-out cells clearly show that the absence of DVL does 
not affect the inactive-state complex between FZD10 and Gα13. In contrast to DVL 
ablation, overexpression of DVL2 abrogated the formation of the complex, indicating that 
although DVL is not essential for FZD10/Gα13-mediated signalling, it can negatively 
regulate this signalling axis. 
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DMR is a live cell assay capable of capturing receptor activation linked to G proteins 
including Gα12/13-dependent activation (Schröder et al., 2010). Similar to experiments 
performed on FZD4, we employed DMR measurements to dissect out FZD10-mediated 
Gα12/13 activation.  Stimulation with the two FZD ligands, WNT-5A and WNT-7A, evoked 
a negative DMR caused by global mass redistribution change of the wild-type cells when 
FZD10 was transiently expressed. In contrast, WNT-7A and WNT-5A were not able to 
induce the same changes in cells with genetic ablation of Gα12 and Gα13. These data 
supports the dcFRAP data where WNT-5A and WNT-7A could induce dissociation of the 
inactive-state complex and further strengthens the proof that FZD10 is able to interact with 
Gα13 and activate downstream signalling events. However, in order to state with certainty 
that the response from FZD10 is exclusively from Gα13, one would need to repeat the 
experiment in Gα13 single knock-out cells in comparison with Gα12 knock-out cells.   
 
4.2.4 Activation of β-catenin-dependent and -independent signalling by FZD10 
(Paper III) 
 
Recently, the WNT signalling pathway has been connected to the hippo pathway and 
activation of the two nuclear effectors YAP and TAZ. In addition to the WNT 
involvement in the signalling of this pathway, the family of Gα12/13 proteins has also been 
shown to regulate the activation of YAP/TAZ (Azzolin et al., 2014; Park et al., 2015; Yu 
et al., 2012b). In order to assess downstream signalling of FZD10/Gα13, we employed a 
8xGTIIC-luciferase reporter assay to measure FZD10-dependent and Gα13-mediated 
YAP/TAZ activation. This assay confirmed that FZD10 was able to induce activation of 
YAP/TAZ through Gα13. Moreover, to prove that activation of Gα13 was necessary for the 
induction of YAP/TAZ activity, we once again took advantage of the RGS-domain of 
p115-RHOGEF, the GAP domain of p115-RHOGEF accelerating the hydrolysis of GTP 
to GDP on the Gα12/13 subunit. Indeed the RGS-domain completely abolished the FZD10-
induced YAP/TAZ activity showing that FZD10 activates Gα13 that in turn induce 
YAP/TAZ transcriptional activity.  
Previously, it has been reported that FZD10 is able to activate β-catenin-dependent 
signalling (Terasaki et al., 2002; Wang et al., 2005). To confirm this and to dissect out the 
difference between YAP/TAZ and β-catenin activation, we performed the TOPFlash 
luciferase reporter assay. Indeed, FZD10 was able to activate β-catenin-dependent 
transcriptional activation. However, in contrast to YAP/TAZ activation FZD10-dependent 
β-catenin activation required LRP6 coexpression.  
The selective preference of FZD10 to particular ligands and G protein isoforms as well 
as its diverse downstream signalling, illustrates the complexity of the WNT signalling 
pathway. In Paper III, we add to our knowledge that FZD10 is also able of activating G 
proteins namely Gα13. While it does not exclude the potential to signal through β-catenin, 
depending on the context, FZD10 has the capability of activating Gα13 downstream effects 
such as YAP/TAZ-mediated transcriptional activation.  
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4.2.5 Possible roles of FZD4/FZD10 mediated Gα12/13 signalling in angiogenesis 
(Paper II & Paper III) 
 
FZD4 is known to be important for the vascular development, in particular in the 
formation of the blood-retina barrier (Wang et al., 2012; Xu et al., 2004; Ye et al., 2009; 
Zhou et al., 2014b). The FZD4-dependent signalling has so far been associated with the 
activation of β-catenin. In Paper II, we identify an additional FZD4/Gα12/13/p115-
RHOGEF-mediated signalling axis. With the knowledge that Gα12/13 dependent signalling 
is crucial for proper blood vessel development our findings further support the role of this 
receptor in vascularisation, both through WNT/β-catenin dependent- and independent 
signalling (Offermanns et al., 1997b; Ruppel et al., 2005; Sivaraj et al., 2013).  
Similar to FZD4, we identified another receptor homolog, FZD10, which mediates Gα13-
dependent signalling to YAP/TAZ. Also YAP/TAZ activation is vital for proper blood 
vessel development (Choi and Kwon, 2015; Choi et al., 2015; Offermanns et al., 1997b). 
In addition, in Paper III, we present RNA expression and protein expression data for 
FZD10 in the developing CNS vasculature by employing in situ hybridization and 
immunohistochemistry. Keeping in mind that FZD4 and FZD10 belong to the same 
subfamily of WNT receptors (Schulte, 2010) and that both are expressed during early 
embryonic development, one could speculate that these two receptors work in a 
coordinated fashion to provide the necessary signalling cues to the developing vasculature.  
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5 GENERAL DISCUSSION AND CONCLUSION 
 
Without blood vessels, the organs of our body would not be functional. Our vasculature 
serves as the main supplier of oxygen and nutrients to our organs, while providing a 
passage for the immune surveillance from pathogens and toxic agents (Engelhardt and 
Liebner, 2014). In order to develop better treatments for severe malignancies like stroke 
and cancer, it is of the utmost importance that we expand our knowledge about the 
vasculature and its development.   
For years, it has been known that WNT signalling is important for the development of 
blood vessels; in particular, the development of CNS vasculature and the BBB (Cattelino 
et al., 2003; Daneman et al., 2009; Liebner et al., 2008; Stenman et al., 2008). WNT 
signalling and its many components are crucial during development, homeostasis and 
tissue regeneration. Perturbation of this pathway is associated with developmental defects 
and severe malignancies including vascular disorders like FEVR and Norrie disease 
(Luhmann et al., 2005; Nikopoulos et al., 2010; Qin et al., 2005; Rehm et al., 2002; 
Robitaille et al., 2002; Toomes et al., 2004). In addition, elevated levels or mutation of the 
components of the pathway are often seen in tumours. While the field has moved forward 
since the discovery of WNT proteins we are still only scratching the surface when it comes 
to understanding and drugging the diverse signalling pathways. With this thesis, I hope to 
broaden the knowledge of WNT signalling and its role in CNS vascular development with 
the intention that this will contribute to better treatments for the associated diseases. 
  Despite the wealth of data supporting the inclusion of FZDs as GPCRs, there is still a 
clear divide in the field and the question is open for debate. FZDs exhibit clear differences 
from classical GPCRs, but are in many ways similar to their distant family members 
(Foord et al., 2005; Schulte, 2010). Modifying multiple proteins of the WNT pathway has 
provided us an insight into how important WNT signalling is in controlling numerous 
cellular processes like proliferation, migration and adhesion (MacDonald et al., 2009b). 
Unfortunately, less emphasis has been placed on the basic pharmacological understanding 
of the structure and mechanism of WNT receptors. The lack of pharmacological tools has 
introduced roadblocks when it comes to studying FZDs. Not only do ten isoforms of the 
receptor exist in mammals, but there are also 19 different ligands that are capable of 
activating the FZDs. Moreover, FZDs are ubiquitously expressed in most cell types. The 
fact that cells often express several isoforms makes it difficult to study WNT activity both 
in vivo and in vitro. In addition, redundancy among FZD isoforms when studying ligand-
receptor specificity or loss-of-function mutations adds to the complexity (Hua et al., 2014; 
Yu et al., 2012c). Lastly, the presence of endogenous FZD ligands and the lack of 
pharmacological tools like synthetic agonists or small peptides that are able to modulate 
WNT signalling are other obstacles slowing down progress in the field.  
In this thesis, we demonstrate that FZD4 and FZD10 two receptors that are in the cluster 
of FZD4, FZD10 and FZD9 share ca. 65% homology (Fredriksson et al., 2003) and are both 
able to activate signalling through the heterotrimeric G protein subfamily of Gα12/13. With 
these results, we support the role of FZDs being GPCRs and activating G protein-
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dependent signalling cascades. While both of these receptors have been associated to the 
β-catenin dependent pathway, activation of G proteins by these receptors does not exclude 
parallel or subsequent activation of β-catenin. It is important to mention that while 
activation of G proteins takes place within seconds or minutes of ligand stimulation, 
activation of β-catenin takes up to an hour and remains persistent over longer time. 
Considering the fact that WNT signalling is important for embryonic development where 
cellular changes occur from second to second and minute to minute, it is important to 
consider that events such as the activation of heterotrimeric G proteins might take place 
before activation of β-catenin regulating more rapid cellular responses (Schulte and Bryja, 
2007). The multiple data existing on WNT signalling pathways surely confirms that in the 
case of the activation of this pathway, the outcome is context dependent.  
While FZD4 has previously been associated with vascular development, its close 
homolog FZD10 has remained unexplored. Both receptors are expressed during early 
embryonic development and although FZD10 has not previously been associated with 
development of the CNS blood vessels, it is worth mentioning that the expression of this 
receptor is strongly dynamic with highest expression levels during the embryonic stages 
when angiogenesis is ongoing. Interestingly, with the RNA sequencing experiments, in 
situ hybridization and immunohistochemistry of embryonic tissue, we show with our data 
that FZD10 mRNA and protein is definitely present in CNS endothelium. Moreover, we 
show that mRNA expression of FZD10 in endothelial cells is declining towards the end of 
angiogenesis. The knowledge that these two receptors belong to the same homology 
cluster and that both can be associated with CNS endothelial cells makes it even more 
interesting that they are both able to activate β-catenin signalling and to form an inactive-
state complex with Gα12/13. Mutants lacking both of these proteins show severe vascular 
defects (Cattelino et al., 2003; Daneman et al., 2009; Offermanns et al., 1997b; Stenman et 
al., 2008). In the case of Gα12/13 mutants, ablation of Gα13 shows a strong vascular 
phenotype while the defects are further amplified when depleting both Gα12 and Gα13. In 
addition, it is worth noting that dissociation of Gα12/13 from the inactive-state complex 
formed with either of these two receptors is induced by stimulation with WNT7A one of 
the two WNT isoforms essential for proper CNS vascular development (Daneman et al., 
2009; Stenman et al., 2008). Considering that no phenotype has been reported to belong to 
perturbed FZD10 signalling and that FZD4 mutants are exhibiting strongest defects in 
retina it is possible that these two receptors are employing a compensatory effect 
considering that both are able to activate the same or similar downstream effectors. For 
this reason it would be desirable to create a double-knockout mouse depleting both of 
these receptors in endothelial cells in order to dissect out their role in vascular 
development.  
In order to improve our knowledge in WNT signalling it is important to gain 
knowledge in the pharmacology of FZDs. The Class FZD GPCRs is some of the least 
studied GPCR families and to be able to take additional steps forward it is important that 
we develop new tools to study this group of unconventional receptors. The lack of read-
out tools and molecules to modify the receptors with is making it further difficult to 
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explore the basic structure and mechanism of these receptors. Though we know that 
receptors such as FZD10 and FZD4 are able to activate β-catenin- and Gα12/13 signalling we 
do not know how the selection between these two routes takes place. Does the activation 
of either molecule depend on the context and additional proteins such as LRP5/6, does it 
depend on the ligand or does it simply depend on the induced confirmation depending on 
the binding site of the ligand. We do know that WNTs can bind to the CRD domain of 
FZDs but so far it has not been demonstrated whether WNTs also bind at the hypothetic 
binding pockets in the receptor core. Different receptor confirmations can be also induced 
by binding of ligands to allosteric sites on the receptor (Kobilka and Deupi, 2007). If 
FZDs contain such sites remains to be elucidated but in order to answer these questions we 
need to continue working on developing correct tools and modifying the existing ones like 
DMR, dcFRAP, FRET and p115-RHOGEF recruitment assay. From a pharmacological 
point of view targeting receptors with drugs is far more desirable than targeting proteins 
like β-catenin, given that modification of for instance β-catenin is opening up for an array 
of off target effects. For this reason we need to improve or knowledge about FZDs in order 
to better understand and in order to be able to better modify the WNT signalling pathway.  
My hope is that I with this thesis have contributed to better understanding of the WNT 
signalling pathway. Although it has been known for years that WNT signalling is 
important for CNS vascular development in this thesis we show that formation of blood 
vessels in the brain depends on a crosstalk between multiple molecules and pathways. 
Moreover we open up the possibility that the WNT receptors expressed by the developing 
endothelium are able of activating other proteins such as heterotrimeric Gα12/13 in order to 
regulate proper vascular development. With this I conclude that in order to understand this 
complex pathway we need to work on developing tools and we need to take advantage of 
the basic pharmacological approaches when studying this pathway. Finally with the hope 
that future research will lead to better treatment for patients we need to keep our mind 
open for the unexpected and not dismiss a hypothesis because we do not yet have the 
possibility or knowledge to test it.  
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